Avadel Pharmaceuticals PLC
NASDAQ:AVDL

Watchlist Manager
Avadel Pharmaceuticals PLC Logo
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Watchlist
Price: 11.8 USD -1.83% Market Closed
Market Cap: 1.1B USD
Have any thoughts about
Avadel Pharmaceuticals PLC?
Write Note

Avadel Pharmaceuticals PLC
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Avadel Pharmaceuticals PLC
Net Income Peer Comparison

Comparables:
PRGO
JAZZ
G
GHRS
COPN
OVB

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Net Income
-$106.2m
CAGR 3-Years
-24%
CAGR 5-Years
-1%
CAGR 10-Years
-8%
Perrigo Company PLC
NYSE:PRGO
Net Income
-$159.6m
CAGR 3-Years
14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Net Income
$463.2m
CAGR 3-Years
N/A
CAGR 5-Years
-5%
CAGR 10-Years
31%
G
GH Research PLC
NASDAQ:GHRS
Net Income
-$35.6m
CAGR 3-Years
-329%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Net Income
€92.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
1%
Ovoca Bio PLC
LSE:OVB
Net Income
-€3.6m
CAGR 3-Years
-1%
CAGR 5-Years
-7%
CAGR 10-Years
8%

See Also

What is Avadel Pharmaceuticals PLC's Net Income?
Net Income
-106.2m USD

Based on the financial report for Jun 30, 2024, Avadel Pharmaceuticals PLC's Net Income amounts to -106.2m USD.

What is Avadel Pharmaceuticals PLC's Net Income growth rate?
Net Income CAGR 10Y
-8%

Over the last year, the Net Income growth was 26%. The average annual Net Income growth rates for Avadel Pharmaceuticals PLC have been -24% over the past three years , -1% over the past five years , and -8% over the past ten years .

Back to Top